Clinical Trials Logo

Financial Stress clinical trials

View clinical trials related to Financial Stress.

Filter by:

NCT ID: NCT04314284 Completed - Colorectal Cancer Clinical Trials

Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity

Start date: May 26, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to incorporate feedback from cancer patients and providers to adapt, implement, and test an intervention. The intervention aims to prompt screening for financial distress, facilitate discussions about care costs with cancer patients, support health insurance selection, and ultimately reduce cancer patients' financial toxicity associated with cancer care.

NCT ID: NCT04135469 Completed - Maternal Distress Clinical Trials

Tax Preparation Pilot

Start date: November 13, 2019
Phase: N/A
Study type: Interventional

The goal of this study to understand what percentage of families in the pediatric clinic at Boston Medical Center (BMC) currently file taxes and use free tax preparation and would accept and use referral to a free tax preparation service. The investigators specifically want to understand which of two methods of connecting to free tax preparation (referral versus navigated connection) is more effective. Also studied will be the feasibility of using surveys on financial wellness and other health indicators to track participants' health. These pilot findings will be used to design a larger study that aims to assess whether integrating free tax preparation services into a pediatric clinic can increase tax filing rates and, as a result, the amount of money families receive in tax refunds. Additionally, the investigators hope to understand whether receiving this service impacts parental stress as well as how parents and babies are using the healthcare system.

NCT ID: NCT04032483 Completed - Financial Toxicity Clinical Trials

A Survey of Financial Toxicity in Rural Cancer Patients

Start date: January 8, 2020
Phase:
Study type: Observational

This project aims to elucidate the prevalence of financial toxicity, identify significant risk factors for toxicity, and understand the burdens of the specific St. Johnsbury rural population. These data will drive future, larger studies to investigate how to alleviate the burden of financial toxicity, especially in vulnerable patient populations.

NCT ID: NCT03963141 Completed - Asthma Clinical Trials

Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A Descriptive Analysis of the Asthma Patient Population in the Emirate of Dubai With Respect to Healthcare Resource Utilization, Costs, and Asthma-related Treatment Pattern

Start date: August 31, 2019
Phase:
Study type: Observational

This Retrospective cohort study with an overall objective of to perform a descriptive analysis of the asthma patient population in the Emirate of Dubai with respect to healthcare resource utilization, costs, and asthma-related treatment patterns and outcome.

NCT ID: NCT03958760 Completed - Diabetes Clinical Trials

Characteristics, Treatment, and Economic Burden of Patients With CVD,CKD or at High Cardiovascular Risk

Start date: February 28, 2021
Phase:
Study type: Observational

The heavy disease burden is mainly due to diabetic complications. Diabetes is a major risk factor for cardiovascular disease (CVD) and chronic kidney disease (CKD).China has been the largest absolute disease burden of diabetes in the world recently1. Diabetic patients with established CVD or CKD are bringing growing pressure upon our nation's healthcare expenditure1. However, the characteristic profile of Chinese diabetic patients who has CVD, CKD or at high risk of CVD remains unclear thus is in urgent need for in-depth investigation.In current China, however, the information regarding diabetes or non-diabetes patients who also had other comorbid conditions (e.g. established CV diseases, CKD or at high risk for such problem), is limited; the patient characteristics, treatment patterns and economic burden may not be fully understood.Therefore, based on TianJin regional database, the investigators will describe the demographic, clinical characteristics, treatment, and economic burden of disease of Chinese diabetic/non-diabetic patients with/without established CV disease, CKD, or at high CV risk including hypertension and hyperlipidaemia. And the investigators believe that the resulting findings will inform a comprehensive group of evidence users to achieve better healthcare for diabetes patients with established or at high risk of CVD or CKD.

NCT ID: NCT03676920 Completed - Cancer Clinical Trials

Feasibility and Utilization of an Application-based Question Prompt List

Start date: August 21, 2018
Phase: N/A
Study type: Interventional

This trial studies how well an application-based question prompt list works in improving treatment cost discussion between patients with breast, prostate, lung, or colorectal cancer and their oncologists. An application-based question prompt list, called Discussion of Cost Application (DISCO App), may help to improve how patients and oncologists discuss cancer treatment costs.

NCT ID: NCT03516942 Active, not recruiting - Clinical trials for Stage III Rectal Cancer AJCC v8

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

Start date: June 11, 2018
Phase:
Study type: Observational

This research trial studies the financial burden in patients with stage I-III colon or rectal cancer who are undergoing treatment. Collecting data from patients about their cost and quality of life may help doctors to better understand the impact of cancer treatment on a patient?s employment and finances.

NCT ID: NCT03506451 Active, not recruiting - Clinical trials for Head and Neck Cancer

PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study

PaRTNer
Start date: June 19, 2018
Phase: N/A
Study type: Interventional

The purpose of this single institution, pilot study is to explore the out of pocket (OOP)costs and financial toxicity of cancer care for patients during definitive treatment of head and neck cancer with radiation therapy with or without chemotherapy and surgical resection. The study team will assess how the financial burden of cancer care impacts quality of life as well as treatment-related decision-making from a patient perspective.

NCT ID: NCT03473379 Recruiting - Cancer Clinical Trials

Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity in Italy

PROFTC-I
Start date: March 1, 2018
Phase:
Study type: Observational

The aim of this study is to develop and validate a patient-reported-outcome instrument (PROFTC-I: Patient Reported Outcome Financial Toxicity in Cancer - Italy) able to describe and measure financial problems of Italian patients receiving cancer treatment.

NCT ID: NCT03035240 Completed - Financial Stress Clinical Trials

Finances First: A Health Intervention in Low Income Single Mother Households

Start date: May 2, 2017
Phase: N/A
Study type: Interventional

The purpose of this prospective, randomized, controlled three-year study is to compare the effect of a year-long financial education program versus usual care on health outcomes in single mother low income households.